Recent studies have suggested that higher circulating levels of leptin, higher leptin receptor expression by the tumor and a high leptin to adiponectin (L:A) ratio all correlate with a worse outcome in several epithelial cancers, including ovarian cancer [18, 19]. This evidence concerns the gene LEPR and ovarian carcinoma.